Patent · US Active

Targeted transposition for use in epigenetic studies

US11306307B2 · kind B2 · utility

4Cited by

6References

26Claims

0Family size

Assignee

ACTIVE MOTIF, INC. · US

Inventors

Mary Anne Jelinek · Carlsbad, US
Brian Stanley Egan · Redding, US
Joseph Fernandez · Carlsbad, US

Key dates

Filing date	Jun 4, 2020
Grant date	Apr 19, 2022
Priority date	—
Expiry date	Jun 4, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/6806
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Disclosed herein are compositions, methods and kits useful for epigenetic analysis based on the use of transposons that are targeted to specific regions of chromatin based on DNA-DNA interactions, protein-protein interactions, RNA-RNA interactions, and nucleic acid-protein interactions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.